
BRC Biotechnology
Shanghai, China brcbiotech.com
From their website, Nov 2026
Work here? Claim this listing
- GLP
- GMP
- ISO 9001
About
BRC Biotechnology provides biosafety testing and quality control services for biopharmaceuticals. It works with antibody drugs, cell and gene therapy, recombinant proteins, vaccines, and nucleic acid drugs for clients supporting IND/BLA submissions. The company operates from Shanghai, China, and Cambridge, Massachusetts, USA.
Services
Antibody Product Testing
Provides cell line characterization, viral clearance studies, unprocessed bulk testing, lot release testing, and genetic stability studies for antibody products such as mAb, ADC, and RDC.
Cell and Gene Therapy Testing
Provides biosafety testing for viral vectors, oncolytic viruses, stem cells, CAR-T/TCR-T, CAR-NK, and TIL products, including viral seed characterization and detection of replication competent virus.
Recombinant Protein Testing
Provides quality testing for recombinant protein products, including microbial bank characterization, unprocessed bulk and lot release testing, and genetic stability studies.
Vaccine Testing
Provides biosafety testing for attenuated, inactive, and subunit vaccines, including microbial bank characterization, viral seed characterization, unprocessed bulk testing, and lot release testing.
Nucleic Acid Drug Testing
Provides testing for mRNA and siRNA products, including microbial bank characterization, plasmid bulk harvest testing, and drug product lot release testing.
Rapid Testing
Provides rapid testing platforms and kits including Celer Q Detection Kit and NGenius®.
Virology Testing
Provides virology testing for porcine and bovine virus detection, exogenous viral factor contamination detection, infectious retrovirus detection, and replication-competent virus detection.
Viral Clearance Studies
Provides viral clearance testing support for biologics development and regulatory submissions.
Animal Testing
Provides animal testing capabilities as part of its biosafety platform.
Capabilities
- Assays and studies
- Antibodies · NGS · Cell therapy · qPCR · CHO · ADCs · Cell line characterization · Viral clearance · Unprocessed bulk testing · Lot release testing · Genetic stability studies · Microbial bank characterization
9 more
Viral seed characterization · Detection of replication competent virus · Sterility · Mycoplasma testing · Adventitious virus testing · Retrovirus testing · Porcine virus detection · Bovine virus detection · Exogenous viral factor contamination detection - Scale and capacity
- 100+ global client audits passed · 100+ IND/BLA submission projects · 6000+ delivered tests · 600+ delivered projects · 40+ commercial projects · 60+ BLA projects
Instruments and platforms
- NGenius® platform
- Transmission Electron Microscopy (TEM)
- PERT assay
- qPCR
- Targeted NGS
- Sanger sequencing
- Multiplex PCR
Modalities and species
- Modalities
- Antibody · ADC · Oligonucleotide · mRNA · Viral vector · Cell therapy · Recombinant protein · Vaccine · Plasmid DNA
- Species and models
- E. coli · CHO cells · HIV
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
FDA registrationListed in FDA database
Listed in the FDA registration database as of Nov 2026
Scope: FDA Establishment Identifier (FEI) · Issued by U.S. FDA · No. 3030103136
ISO 9001:2015Self-reported
GLPSelf-reported
Company
- Type
- Testing lab
Locations
- Address
- 625 Mt Auburn Street, Suite 105 Cambridge, MA 02138
- Sites
- Shanghai, China
- Serves
- global
Public records
- FDA establishment
- 3030103136
Similar labs
Work here? Claim this listing